Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Pedram Mizani, MD, MHSA, CEO of AmeriClerkships, speaks at the 2010 AMA Annual Meeting, discusses the concept of acculturation. This means training doctors from early on learn culturally…
Diana Ramos, MD, MPH, delegate of the AMA Minority Affairs Consortium, talks at the annual AMA delegation about the importance of simplifying labeling to decrease obesity. Standards for…
Kenneth Simons, MD, Chair of the Section of Medical Schools at AMA, talks at the Annual AMA Delegation about the challenges in medical education, the first of which…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Michael J. Manos, MD, PhD, Head of the Center for Pediatric Behavioral Health, Children’s Hospital, Cleveland Clinic, discusses ADHD and describes some of the benefits of having this…
NEW YORK (Reuters Health) – The reported sensitivity of numerous blood-based markers proposed for the early detection of colorectal cancer (CRC) are probably higher than might be expected…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
NEW YORK (Reuters Health) – Senior investigator Dr. Henry T. Akinbi of Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, provided this perspective in…
